Western blot analysis revealed that imatinib at 5 μM induced a 5.8-fold reduction in phosphorylated SAMHD1, indicating potential interference with CD4 + permissivity to HIV reverse transcription, whereas imatinib at 1.25 μM induced only a partial reduction that did not reach statistical significance (Fig. 1 b).
← all excerpts
Primary HIV infection during chronic treatment with imatinib: impact on infection dynamics
1
—
—